美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Ipsen S.A.

29.34

+0.31601.09%

成交量：761.00

成交額：2.23萬

市值：96.94億

市盈率：13.44

高：29.34

開：29.34

低：29.34

收：29.02

資料載入中...

總覽公司新聞公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞

益普生2025年第一季度實現穩健業績增長並確認全年業績指引

在所有治療領域強勁業績的推動下，益普生2024年實現穩健業績增長並確認2025年全年指引

益普生2024年前三季度實現強勁的銷售勢頭並上調2024年全年指引

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/IPSEY"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IPSEY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IPSEY\",,,,,undefined,":{"symbol":"IPSEY","market":"US","secType":"STK","nameCN":"Ipsen S.A.","latestPrice":29.34,"timestamp":1747771200000,"preClose":29.024,"halted":0,"volume":761,"delay":15,"floatShares":112371575,"shares":330397936,"eps":2.183055,"marketStatus":"盤前交易","change":0.316,"latestTime":"05-20 16:00:00 EDT 延時","open":29.34,"high":29.34,"low":29.34,"amount":22274.763799999997,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":2.183055,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1747834200000},"marketStatusCode":1,"adr":0,"adrRate":0.25,"exchange":"PINK LIMITED","adjPreClose":29.34,"volumeRatio":1.005018728081578},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IPSEY\",,,,,undefined,":{"symbol":"IPSEY","floatShares":112371575,"roa":"8.22%","roe":"8.93%","lyrEps":2.152613,"volumeRatio":1.005018728081578,"shares":330397936,"dividePrice":0.326,"high":29.34,"amplitude":0,"preClose":29.024,"low":29.34,"week52Low":25.11,"pbRate":"2.05","psRate":"2.39","week52High":34.06,"institutionHeld":0,"latestPrice":29.34,"eps":2.183055,"divideRate":0.011111,"volume":761,"delay":15,"ttmEps":2.183055,"open":29.34,"prevYearClose":28.97,"prevWeekClose":28.55,"prevMonthClose":28.2,"prevQuarterClose":29.2225,"fiveDayClose":28.46,"twentyDayClose":26.295,"sixtyDayClose":28.25},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/IPSEY\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IPSEY\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2528906912","title":"益普生2025年第一季度實現穩健業績增長並確認全年業績指引","url":"https://stock-news.laohu8.com/highlight/detail?id=2528906912","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528906912?lang=zh_tw&edition=fundamental","pubTime":"2025-04-18 17:35","pubTimestamp":1744968900,"startTime":"0","endTime":"0","summary":"确认2025年全年财务指引。巴黎2025年4月18日 /美通社/ -- 全球特药领域生物制药公司益普生于4月16日公布了2025年第一季度的财务业绩。对益普生而言，2025年将是重要的一年，多个产品即将上市，我们的产品组合有望达成多项里程碑。\" 全年指引 益普生确认了2025年全年财务指引：  以固定汇率计算，总销售额增长超过5.0%。集团再融资 益普生于3月19日宣布成功完成其首次5亿欧元的评级公募债券发行，票面利率为3.875%，于2032年3月到期。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4667912_ZH67912_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK4007","IPSEY","IPN"],"gpt_icon":0},{"id":"2512529945","title":"在所有治療領域強勁業績的推動下，益普生2024年實現穩健業績增長並確認2025年全年指引","url":"https://stock-news.laohu8.com/highlight/detail?id=2512529945","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512529945?lang=zh_tw&edition=fundamental","pubTime":"2025-02-17 17:58","pubTimestamp":1739786280,"startTime":"0","endTime":"0","summary":"本年度还与Skyhawk Therapeutics签署了一项合作协议，开发用于治疗罕见神经系统疾病的RNA调节小分子药物。环境、社会和治理 2024年，益普生采取了重要步骤，以实施可持续发展战略的宏伟目标。经过密集转型项目，目前益普生全球99.8%的电力来自可再生能源。2025年财务指引 益普生为2025财年制定了以下财务指引，其中排除了潜在的后期业务开发交易的任何影响：  以固定汇率计算，总销售额增长超过5.0%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4620551_ZH20551_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK4505","ALGS","BK4080","IPSEY","BK4139","BK4231","BK4007","ADC","IPN"],"gpt_icon":0},{"id":"2478178251","title":"益普生2024年前三季度實現強勁的銷售勢頭並上調2024年全年指引","url":"https://stock-news.laohu8.com/highlight/detail?id=2478178251","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2478178251?lang=zh_tw&edition=fundamental","pubTime":"2024-10-28 15:07","pubTimestamp":1730099220,"startTime":"0","endTime":"0","summary":"巴黎2024年10月28日 /美通社/ -- 全球特药领域生物制药公司益普生于近日公布了2024年前三季度及2024年第三季度的业绩。在今年前三季度业绩的支持下，我们将进一步上调2024年的销售额和利润指引。\" 2024年全年指引 基于第三季度的强劲业绩，益普生已进一步上调2024年的财务指引：  按固定汇率计算，总销售额增长率超过8.0%。作为协议的一部分，益普生在第三季度收到1.58亿美元的现金支付。预计该交易将于2024年年底前完成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4540288_ZH40288_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["ALGS","BK4505","BK4139","IPN","BK4007","IPSEY"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IPSEY\",params:#limit:5,,,undefined,":[{"date":"2024-07-25","symbol":"IPSEY","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1721894400000,"name":null,"time":"","dateTimestamp":1721880000000,"actualEps":null},{"date":"2024-05-31","symbol":"IPSEY","amount":0.235267,"announcedDate":"2024-05-20","type":"dividend","market":"US","newRecordDate":"2024-05-31","defaultRemindTime":1717162200000,"name":"Ipsen S.A.","recordDate":null,"payableDate":"2024-05-31","currency":"USD","dateTimestamp":1717128000000,"payDate":null},{"date":"2023-06-02","symbol":"IPSEY","amount":0.324045,"announcedDate":"2023-05-19","type":"dividend","market":"US","newRecordDate":"2023-06-05","defaultRemindTime":1685712600000,"name":"Ipsen S.A.","recordDate":"2023-06-27","payableDate":"2023-06-05","currency":"USD","dateTimestamp":1685678400000,"payDate":"2023-06-27"},{"market":"US","date":"2022-10-26","symbol":"IPSEY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1666756800000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2022-07-28","symbol":"IPSEY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1658980800000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IPSEY\",market:\"US\",,,undefined,":[{"executeDate":"2015-05-26","recordDate":"2015-05-28","paymentDate":"2015-07-06","value":0.1498,"currency":"USD"},{"executeDate":"2016-05-31","recordDate":"2016-06-02","paymentDate":"2016-07-13","value":0.177552,"currency":"USD"},{"executeDate":"2021-05-28","recordDate":"2021-06-01","paymentDate":"2021-06-09","value":0.275217,"currency":"USD"},{"executeDate":"2022-05-31","recordDate":"2022-06-01","paymentDate":"2022-06-09","value":0.315063,"currency":"USD"},{"executeDate":"2023-06-02","recordDate":"2023-06-05","paymentDate":"2023-06-27","value":0.324045,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IPSEY\",market:\"US\",delay:false,,,undefined,":{}}}